ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IMM Immupharma Plc

2.10
-0.025 (-1.18%)
Last Updated: 13:05:41
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.025 -1.18% 2.10 2.10 2.16 2.20 2.10 2.20 112,953 13:05:41
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -1.93 7.33M
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 2.13p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 3.78p.

Immupharma currently has 333,403,115 shares in issue. The market capitalisation of Immupharma is £7.33 million. Immupharma has a price to earnings ratio (PE ratio) of -1.93.

Immupharma Share Discussion Threads

Showing 23226 to 23249 of 39125 messages
Chat Pages: Latest  941  940  939  938  937  936  935  934  933  932  931  930  Older
DateSubjectAuthorDiscuss
06/4/2018
08:01
Immupharma £15 billion takeover target.
englishlongbow
06/4/2018
08:01
Are we nearly there yet?
ewads
06/4/2018
08:00
10k bought on bell
opodio
06/4/2018
07:58
Dr Bio. Thanks. We now know your agenda. Your posts carry zero value.
roundup
06/4/2018
07:58
The share is so moreish. makes me want to just buy more but thats because it becomes a constant money machine soon, a golden goose, 96% margins on ANNUAL £100bn sales including other indications
opodio
06/4/2018
07:57
Looks like a gaggle of golden geese to me. What about the other platforms?
runtoma
06/4/2018
07:55
must pain these guys like Dr Bio and hamham watching from the outside looking in and watching price go into orbit

if i see big buy trades in today i will triple large positions. Ready to mobilise troops as we go over 180p and look forward to 600p next week

opodio
06/4/2018
07:55
Level 2 early indicators 170/175
ny boy
06/4/2018
07:54
it becomes a constant money machine, a golden goose, 96% margins on ANNUAL £100bn sales including other indications

yesterdays 250k buyer may have had early peek at P3 results...smiling

opodio
06/4/2018
07:53
How expensive do you think an RNS is?They haven't issued an RNS because the data isn't locked yet. The working day has hardly started: I would expect an announcement later today or possibly even Monday morning.
longshanks
06/4/2018
07:53
you smell like a gone off ham
opodio
06/4/2018
07:50
it becomes a constant money machine, a golden goose, 96% margins on ANNUAL £100bn sales including other indications

yesterdays 250k buyer may have had early peek at P3 results...smiling

opodio
06/4/2018
07:49
Chart shows we have broken through the upside of the trend channel and heading to test 190p resistance.
ny boy
06/4/2018
07:46
it becomes a constant money machine, a golden goose, 96% margins on ANNUAL £100bn sales including other indications
opodio
06/4/2018
07:44
Look out for the £15 billion takeover announcement.
englishlongbow
06/4/2018
07:37
They may shortly be....
glennrcharles
06/4/2018
07:36
They’re not going to post a very expensive RNS to tell us what we already know. They’re not made of money
pretax2
06/4/2018
07:36
Imo, RNS for the locking of data will be issued today. We know professor Muller will be talking about Lupuzor at the conference on Monday. In fact I would not be surprised if following the locking of data today, they announce the P3 results on Monday prior to the conference call. It makes sense to do it that way. This is how I interpret it and it is my personal view.
hjs
06/4/2018
07:30
My prediction is that Lupuzor will replace Benlysta as "many drugs have failed lupus trials because they try to suppress the immune system" - and this is where Lupuzor comes at the top and and this is the breakthrough.
Regarding anyone questioning, out of the blue "this or that", please be reminded that the IMM Scientific Team is from the prestigious CNRS and have donkeys of years of experience and they know exactly what they are doing. So when Lupuzor replaces Benlysta, I am sure there will be many who will retire earlier than expected.

fuji99
06/4/2018
07:25
28 March 2018



ImmuPharma PLC

("ImmuPharma" or the "Company")



Appointment of Joint Broker



ImmuPharma PLC (AIM: IMM.L), the specialist drug discovery and development company, is pleased to announce that it has with immediate effect appointed Bryan, Garnier & Co. Limited as its joint corporate broker to act alongside Northland Capital Partners who remain the Company's Nominated Adviser and joint corporate broker.



Tim McCarthy, Chairman of ImmuPharma, commented: "We welcome Bryan Garnier as Joint Broker. Bryan Garnier provides ImmuPharma with deep healthcare expertise and pan European broking capability, to support the Company as we progress towards commercialisation."



Olivier Garnier, Founder and Managing Partner of Bryan, Garnier & Co. commented: "We are delighted to be appointed and we look forward to working with the Company at this very exciting time."

opodio
06/4/2018
07:25
opodio - coockoo!
hamhamham1
06/4/2018
07:24
buy at 600p next week babies
opodio
06/4/2018
07:20
Are we there yet?
ewads
06/4/2018
07:20
Dr biotech great post
best1467
Chat Pages: Latest  941  940  939  938  937  936  935  934  933  932  931  930  Older

Your Recent History

Delayed Upgrade Clock